关于瘤病毒治疗恶性质瘤临床状态,挑战和未来方向的最新情况
Georgios M Stergiopoulos1, Susanna C Concilio2, Evanthia Galanis3,4
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
Current treatment options in oncology
|June 19, 2024
概括
瘤病毒 (OVs) 显示出治疗恶性质瘤 (如质母细胞瘤 (GBM)) 的前景. 这些病毒有选择性地杀死癌细胞,并可以刺激抗瘤免疫力,潜在地改善患者的治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 恶性质质瘤,包括质母细胞瘤 (GBM),是具有有限治疗选择的侵袭性脑瘤.
- 瘤病毒 (OVs) 正在成为对GBM的有前途的治疗策略.
- 一种OV,Teserpaturev (Delytact®),已在日本获得GBM治疗的临时批准.
研究的目的:
- 审查瘤病毒 (OV) 在治疗恶性质瘤方面的潜力.
- 讨论OVs如何重塑瘤微环境并增强抗瘤免疫力.
- 要突出从最近的临床试验的见解,以未来的治疗个性化.
主要方法:
- 审查目前的临床试验,涉及瘤病毒恶性质瘤.
- 对OV机制的分析,包括选择性向癌细胞和免疫调节.
- 检查将OVs与免疫治疗结合在一起的策略.
主要成果:
- OVs证明了选择性的向和消除癌细胞.
- OVs可以改变瘤微环境以促进抗瘤免疫力.
- 最近的试验提供了优化OV治疗和患者选择的数据.
结论:
- 瘤病毒通过直接攻击瘤和刺激免疫反应,为对抗恶性质瘤提供了一种新的方法.
- 将OV与免疫调节有效载荷或免疫治疗结合起来,可能会提高治疗效率.
- 未来的临床试验和患者预选择对于最大限度地提高在GBM中瘤治疗病毒疗法的成功至关重要.
相关概念视频
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511